News Quantified

CRNX – crinetics pharmaceuticals, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Crinetics Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024 [Yahoo! Finance]

Crinetics Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024

Crinetics Pharmaceuticals Announces April 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More [Yahoo! Finance]

Crinetics (CRNX) Up as Second Acromegaly Study Meets Goals [Yahoo! Finance]

-4.3%

MISS

-3.1%

MISS

Market Outperform

Market Outperform

Market Outperform

Market Outperform

Market Outperform

Market Outperform

Form ARS Crinetics Pharmaceutical For: Dec 31

Form DEFA14A Crinetics Pharmaceutical

Form DEF 14A Crinetics Pharmaceutical For: Apr 25

Form 4 Crinetics Pharmaceutical For: Apr 18 Filed by: Struthers Richard Scott

Form 4 Crinetics Pharmaceutical For: Apr 15 Filed by: Pizzuti Dana

Top News Gainers

3/16 Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 15.3%

4/4 Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $35.00 price target on the stock. 11.0%

4/14 Form 424B5 Crinetics Pharmaceutical 7.6%

9/25 Crinetics Pharmaceuticals to Participate in Cantor Global Healthcare Conference 6.3%

1/8 Crinetics Pharmaceuticals to Present at J.P. Morgan Healthcare Conference 5.6%

8/7 Form 4 Crinetics Pharmaceutical For: Aug 05 Filed by: Struthers Richard Scott 5.5%

4/20 Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 5.5%

3/4 Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 4.9%

3/27 Form 3 Crinetics Pharmaceutical For: Mar 20 Filed by: Madan Ajay 4.1%

11/26 Crinetics Pharmaceuticals to Participate in the Piper Jaffray Healthcare Conference 4.1%

Top News Decliners

3/11 Form 4 Crinetics Pharmaceutical For: Mar 09 Filed by: Vivo Opportunity, LLC -14.9%

4/6 Crinetics Pharmaceuticals Reports Positive Interim Results for the ACROBAT Edge Phase 2 Trial of Paltusotine (CRN00808) in Acromegaly Patients and Provides Corporate Update -10.9%

3/9 Q4/2019 12/31/2019 EPS -0.600 ZacksConsensus -0.670 ActVsEst 0.070 - Beat -9.4%

8/13 Q2/2019 6/30/2019 EPS -0.510 ZacksConsensus N/A ActVsEst N/A - N/A -7.2%

7/29 Crinetics Pharmaceuticals to Receive Final Award of SBIR Grant from NIH for Congenital Hyperinsulinism -5.7%

4/23 Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -5.1%

2/25 Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) was downgraded by analysts at TheStreet from a "c-" rating to a "d" rating. -4.3%

1/11 Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) was upgraded by analysts at TheStreet from a "d" rating to a "c-" rating. -3.5%

2/26 Form 4 Crinetics Pharmaceutical For: Feb 24 Filed by: Struthers Richard Scott -3.2%

2/6 Form SC 13G/A Crinetics Pharmaceutical Filed by: 5AM Ventures IV, L.P. -2.8%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day